E. Rojas

5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer.

J. Cubiella, D. Nicolás-Pérez, A. Goel, 2011, Gastroenterology.

Utility of p16 Immunohistochemistry for the Identification of Lynch Syndrome

A. Carrato, G. Enders, S. Benlloch, 2009, Clinical Cancer Research.

IGFBP3 Methylation Is a Novel Diagnostic and Predictive Biomarker in Colorectal Cancer

C. Boland, Y. Toiyama, A. Goel, 2014, PloS one.

TFAP2E Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal Cancer

A. Goel, F. Balaguer, M. Andreu, 2018, Clinical Cancer Research.

Expression of molecular markers in mediastinal nodes from resected stage I non-small-cell lung cancer (NSCLC): prognostic impact and potential role as markers of occult micrometastases.

M. Sánchez-Ronco, S. Benlloch, J. Galbis-Caravajal, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

FFPE samples from cavitational ultrasonic surgical aspirates are suitable for RNA profiling of gliomas

L. M. Valor, C. Alenda, E. Rojas, 2021, PloS one.

Prevalence of Lynch Syndrome among Patients with Newly Diagnosed Endometrial Cancers

F. Aranda, G. Peiró, C. Alenda, 2013, PloS one.

Comparison Between Universal Immunohistochemistry for Mismatch Repair Proteins Versus Revised Bethesda Guidelines in the Detection of Patients With Lynch Syndrome

Á. Carracedo, M. Andreu, A. Castells, 2011 .

Methylation analysis of MLH1 improves the selection of patients for genetic testing in Lynch syndrome.

Antoni Castells, Adela Castillejo, Xavier Llor, 2010, The Journal of molecular diagnostics : JMD.

5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer.

J. Cubiella, F. Balaguer, M. Andreu, 2011, Gastroenterology.